Skip to main content
. 2015 May 12;100(7):2743–2750. doi: 10.1210/jc.2015-1158

Table 3.

Performance of the Multiplatform miRNA and Mutation Test

Cohort, % (95% CI) AUS/FLUS, % (95% CI) FN/SFN, % (95% CI)
No. of cases 109 58 51
Sensitivity 89 (73–97) 94 (73–100) 82 (57–96)
Specificity 85 (75–92) 80 (64–91) 91 (76–98)
PPV 74 (58–86) 68 (46–85) 82 (57–96)
NPV 94 (85–98) 97 (84–100) 91 (76–98)
Odds ratio 44 (13–151) 68 (8–590) 48 (9–269)